skip to main content

    Updated Visitor Guidelines

 

MENU

 

What is Treated

CAR T-cell Therapy has been approved by the U.S. Food and Drug Administration for:

Frequently Asked Questions About CAR T-cell Therapy

What is CAR T-cell therapy?

CAR T-cell is a type of cellular therapy. We take immune cells out of a patient’s body, and then we modify these cells so that they can target and kill cancer cells. Then we reinfuse these cells into the patient. The cells go into the patient, find their target on the cancer cell surface and kill those cells.

Dlugosz to oversee basic science research at Rogel Cancer Center

The University of Michigan Rogel Cancer Center has named Andrzej Dlugosz, M.D., associate director for basic science research. He currently co-leads the Rogel Cancer Center’s cancer biology program. In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs.

An Interactive Website Boosts Genetic Testing Knowledge in Breast Cancer Patients

A team at the University of Michigan Rogel Cancer Center recently sought to determine how much newly diagnosed cancer patients understand about the benefits of genetic testing after a diagnosis. Their other objective: to find out whether a decision support tool would help improve that knowledge.

Radiation therapy outcomes better for African-American prostate cancer patients than Caucasian patients

While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy.

Pages